ArticleBMC cancer2026

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

Akihiro Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.